Lilly’s $400 Billion Surge Reshapes Big Pharma, Rally
Eli Lilly has added roughly $400 billion in market value over the past year, fueling a dramatic shift in Big Pharma a...
This intro explains what a high index level may indicate in terms of trend strength, momentum, and potential market overheating.
25,925 articlesEli Lilly has added roughly $400 billion in market value over the past year, fueling a dramatic shift in Big Pharma a...
A ChatGPT-powered forecast associated with Sam Altman lays out a bullish Bitcoin scenario for late 2026, highlighting...
Jim Cramer argues that the MAG 7 must be analyzed separately, not as a single basket, outlining five core reasons eac...
Bahrain’s EDB chief Noor outlines a growth-focused strategy to lure capital despite regional headwinds. bahrain edb’s...
Jim Cramer challenges a fresh downgrade on Apple, arguing the stock’s AI ambitions and a possible 2027 supercycle jus...
Oracle is at a crossroads: AI-enabled cloud growth and savvy capital management could unlock significant upside. Here...
A baby boomer dad who spent years cleaning overnight helped his five children attend a private college tuition-free, ...
The U.S. pressed a tenth consecutive night of airstrikes on Iran as shipping in the Hormuz Strait faced renewed risk,...
A long-running insurer broker, founded in 1941, has quietly raised its dividends for decades and now offers a compell...
Investors who rode Nvidia's AI surge may wonder if the stock remains a millionaire-maker. This guide weighs the facto...
A single, fixable flaw undermines most households' budgets: the failure to automate saving and bill payments. Here's ...
Six non-AI chip makers could be poised to benefit from the AI boom, as demand broadens beyond headline AI chips. Here...